Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Uniformity of Dosage Units in Transdermal Patches

Posted on By

SOP for Uniformity of Dosage Units in Transdermal Patches

Standard Operating Procedure for Uniformity of Dosage Units in Transdermal Patches

1) Purpose

To establish procedures for testing the uniformity of dosage units in transdermal patches to ensure consistency in drug content and adherence to quality standards.

2) Scope

This SOP applies to the quality control department responsible for performing uniformity of dosage units testing on transdermal patches during production.

3) Responsibilities

3.1 Quality Control Analyst: Perform uniformity testing according to defined procedures.
3.2 Production Supervisor: Provide samples for testing in accordance with sampling plans.
3.3 QA Personnel: Review and approve testing procedures and results.
3.4 Production Operators: Assist in sample collection and preparation for testing.

See also  SOP for Cleaning Validation in Transdermal Patches Production

4) Procedure

4.1 Sample Collection:

4.1.1 Collect representative samples of transdermal patches from production batches based on sampling plan.

4.1.2 Ensure samples are labeled with batch information and identification numbers.

4.2 Testing Method:

4.2.1 Prepare transdermal patches for testing by cutting into appropriate units or sections.

4.2.2 Perform assay or content uniformity testing using validated analytical methods.

4.3 Data Analysis:

4.3.1 Analyze test results to determine the uniformity of drug content across dosage

units.

4.3.2 Calculate and compare drug content per unit against acceptance criteria specified in approved specifications.

4.4 Reporting:

4.4.1 Document testing procedures, results, and observations in designated test records or laboratory notebooks.

See also  SOP for Quality Control Testing of Transdermal Patches

4.4.2 Prepare test reports summarizing uniformity testing outcomes and compliance with specifications.

4.5 Documentation:

4.5.1 Maintain comprehensive records of uniformity testing activities, including raw data and calculations.

4.5.2 Archive test reports and related documentation for review and audits as per document control procedures.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QA: Quality Assurance

6) Documents, if any

Uniformity Testing Protocols
Test Reports
Batch Production Records

7) Reference, if any

USP General Chapter 905: Uniformity of Dosage Units
ICH Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products

8) SOP Version

Version 1.0

See also  SOP for Conducting Process Validation for Transdermal Patches
Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Pharmacovigilance Regulatory Intelligence Monitoring
Next Post: SOP for Labeling of MDIs

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version